Fadi FAKHOURI
Nantes University Hospital · Nantes CHU · Hôpital Necker, PARIS
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Fadi FAKHOURI as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 00:27 UTC. Open this list on ClinicalTrials.gov
- N/ANCT02954705 · MICRO-RNAs OF NEUTROPHILS IN RENAL ANTINEUTROPHIL CYTOPLASMIS ANTIBODY (ANCA) -ASSOCIATED VASCULITISNantes University Hospital · completed · ANCA-associated Vasculitis · principal investigator
- Ph4NCT02574403 · Study Assessing an Algorithm-based Strategy of Eculizumab Discontinuation in Children and Adults With aHUSNantes University Hospital · completed · Atypical Hemolytic Uremic Syndrome · study director
- N/ANCT00426686 · ADAMTS13 in Thrombotic Thrombocytopenic PurpuraAssistance Publique - Hôpitaux de Paris · completed · Thrombotic Thrombocytopenic Purpura · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 00:27 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 00:27 UTC. The ranking covers the 200 most relevant of 7 PubMed records, and a shared surname and initials can bring in a namesake. All 7 on PubMed
- Terminal Complement Inhibitor Eculizumab in Adult Patients With Atypical Hemolytic Uremic Syndrome: A Single-Arm, Open-Label Trial.Am J Kidney Dis · 2016254 citationsRCR 11.0
- 219 citationsRCR 6.6
- 155 citationsRCR 11.4
- Rituximab for minimal-change nephrotic syndrome in adulthood: predictive factors for response, long-term outcomes and tolerance.Nephrol Dial Transplant · 201459 citationsRCR 2.2
- Trial of Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGN.N Engl J Med · 202543 citationsRCR 14.8
- Digital application developed to evaluate functional results following robot-assisted radical prostatectomy: App for prostate cancer.Comput Methods Programs Biomed · 202012 citationsRCR 0.7